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Abstract
Background: Although several reports demonstrate the efficacy of stress echocardiography in diagnosing coronary
artery disease, comparable studies on the competence of the same imaging technique at rest are limited. This
study aimed to evaluate whether ventricular akinesia/hypokinesia and left ventricular ejection fraction (LVEF) < 55 %
at rest are useful in predicting abnormal coronary angiography.
Methods: This study prospectively enrolled 100 diagnostic coronary catheterization candidates. Any routine
echocardiography that the candidates had undergone before diagnostic coronary catheterization was reviewed.
Patients were subclassified according to the presence and location of ventricular akinesia/hypokinesia, LVEF, and the
results of diagnostic coronary catheterization. LVEF < 55 % was considered below the normal physiological limit.
Abnormal coronary angiography was defined as narrowing of half or more of the caliber of at least one major
coronary artery.
Results: Abnormal coronary angiography was significantly associated with akinesia/hypokinesia (OR = 4.85, P = 0.002)
and LVEF < 55 % (OR = 5.75, P = 0.001). Screening of akinesia/hypokinesia and LVEF < 55 % as diagnostic tools
for abnormal coronary angiography achieved comparable sensitivities (87.2 % vs. 88.9 %), specificities (41.5 vs.
41.8), and diagnostic accuracies (41.5 vs. 41.8). Left ventricular anterior wall akinesia/hypokinesia achieved a
higher diagnostic odds ratio (9.7), sensitivity (95 %), and negative predictive value (96.4 %) compared with
other types of akinesia/hypokinesia.
Conclusion: The overall diagnostic accuracy of akinesia/hypokinesia and LVEF < 55 % to predict abnormal
coronary angiography was poor, probably owing to significant influences of macro- as well as micro-vascular
ischemia on left ventricular function.
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Background
Myocardial ischemia is known to depress cardiac con-
tractility [1]. Reduction of left ventricular wall motion
(LVWM) and/or ejection fraction (LVEF) usually indi-
cates myocardial ischemia unless proven otherwise [2].
Depressed left ventricular function (LVF) is likely,
whether myocardial ischemia is owing to compromised
function of large epicardial vessels [3] or the microcircu-
lation of the heart [4, 5]. The presence of clinical fea-
tures of myocardial ischemia usually indicates coronary
artery disease (CAD) [6]. In such patients, failure of the
coronary angiography to demonstrate apparent, or in-
duced, narrowing of the large coronary vessels redirects
the possible diagnosis towards microvascular ischemia of
the myocardium. Cardiac syndrome X (CSX) is com-
monly used to describe the triad of: typical cardiac chest
pain, significant changes in one or more of the cardiac
stress test(s), and normal angiography of the epicardial
coronary vessels [7, 8].
Cardiac stress tests evaluate the possible ischemic elec-
trocardiography (ECG) changes, depressed LVWM or
LVEF while heart activity is increased by exercise or
other inotropic factors [9, 10]. Although there are
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several reports on the efficiency of stress echocardiog-
raphy in the diagnosis of CAD [11, 12], comparable
studies on the competence of the same technique at rest
are limited [13]. Clinicians in developing countries
are usually forced to use resting ECG and echocardi-
ography for the diagnosis and risk stratification of
CAD patients, owing to a lack of facilities and poor
financial resources. In Sudan, selection of candidates
for diagnostic coronary catheterization (DCC) is partly
dependent on depressed LVWM and/or LVEF on rest-
ing echocardiography. The present study aimed to
evaluate ventricular akinesia/hypokinesia and LVEF < 55 %
derived from resting echocardiography as screening tests
for the detection of abnormal coronary angiography
(ACA). This is the first study to evaluate these two mea-
sures as screening tools for ACA in Sudan and probably
worldwide.
Methods
This study received clearance from the Ethics Review
Committee of the Faculty of Medicine, Khartoum
University, Sudan. Written informed consent was pro-
vided by each volunteer before being enrolled in the
study.
This study prospectively enrolled 100 diagnostic cor-
onary catheterization (DCC) candidates in Al-Shaab
Cardiac Center, Khartoum, Sudan. Following evaluation
of sociodemographic characteristics, past medical his-
tory, and clinical examination of each patient, results of
routine echocardiography conducted before DCC were
reviewed. Patients were subclassified according to the
presence and location of ventricular akinesia/hypokinesia,
LVEF, and the results of DCC. The endocardial and epi-
cardial motion, as well as thickening of each segment of
the LV, were assessed to assign a wall motion score
index (WMSI). Normal wall thickening (WMSI = 1)
was considered indicative of normokinesia, while de-
creased (WMSI = 2) and absent (WMSI = 3) wall thicken-
ing were considered indicative of hypokinesia and akinesia
respectively. Left ventricular anterior (LVAW), septal
(LVSW), inferior (LVIW), and lateral (LVLW) walls were
assessed for the presence of akinesia/hypokinesia, irre-
spective of which particular part of the wall was affected.
According to the 16-LV segmentation model, LVSW
included the basal anteroseptal, basal inferoseptal, mid-
anteroseptal, mid-inferoseptal, and apical parts of the in-
terventricular septum; LVAW included the basal, mid, or
apical parts of the anterior LV wall; LVIW included the
basal, mid, or apical parts of the inferior LV wall; and
LVLW included the basal anterolateral, basal inferolateral,
mid-anterolateral, mid-inferolateral, and apical parts of
the lateral wall. LVEF < 55 % was considered to be below
the normal physiological limit [14]. Patients with narrow-
ing of half or more of the caliber of one or more of the
major coronary arteries were considered to have ACA
[15]. The following formula was used to estimate body
mass index (BMI):
BMI Kg=m2
  ¼ weight kgð Þ= height m2 :
Statistical analysis was performed using OpenEpi soft-
ware, version 2.3, and Statistical Package for the Social
Sciences (SPSS) for Windows, version 16.0 (SPSS Inc.,
Chicago, IL, USA). Studied variables were described as
the mean ± standard deviation. Proportions of the stud-
ied groups were expressed as percentages (%) and 95 %
confidence intervals (CI). The unpaired t-test was used
to evaluate differences in the means of the studied
variables between patients with normal coronary angio-
gram (NCA) and ACA. The binary logestic regression
was used to evaluate the association between ACA
and akinesia/hypokinesia as well as LVEF < 55 %. Sen-
sitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV), diagnostic accuracy
(DA), likelihood ratio of a positive test (LRP), likeli-
hood ratio of a negative test (LRN), and diagnostic
odds ratio (DOR) were calculated to evaluate akinesia/
hypokinesia and LVEF < 55 % as screening tests for ACA.
P < 0.05 was considered significant.
Results
Coronary angiography confirmed CAD in 72 of 100 pa-
tients subjected to DCC (72 %, 95 % CI 62.5–79.9 %).
Eight of the subjects with NCA were male (28.6 %, 95 %
CI 15.3–47.1 %), and 53 of the subjects with ACA were
male (73.6 %, 95 % CI 62.4–82.4 %). Characteristics of
the studied groups are given in Table 1. Patients with
ACA were significantly older (59.58 ± 9.80 years) and
had a significantly lower BMI (25.70 ± 3.97 kg/m2) com-
pared with those with NCA (49.11 ± 8.16 years, 29.58 ±
4.96 kg/m2; P < 0.001). ACA was significantly associated
with male sex (OR = 6.97, P < 0.001), diabetes mellitus
(OR = 3.89, P = 0.013), akinesia/hypokinesia (OR = 4.85,
P = 0.002; Fig. 1), and LVEF < 55 % (OR = 5.75, P = 0.001;






N = 28 N = 72
M (SD) M (SD)
Age (Years) 49.11 (8.16) 59.58 (9.80) <0.001
BMI (kg/m2) 29.58 (4.96) 25.70 (3.97) <0.001
SBP (mmHg) 129.25 (18.83) 129.49 (24.87) 0.963
DBP (mmHg) 77.64 (11.42) 77.94 (13.06) 0.918
LVEF (%) 59.50 (9.77) 52.10 (12.69) 0.003
M mean, SD standard deviation, BMI body mass index, SBP systolic blood
pressure, DBP diastolic blood pressure, LVEF left ventricular ejection fraction
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Fig. 2). Evaluation of akinesia/hypokinesia and LVEF < 55 %
as screening tests for ACA revealed highly comparable
conditional ratios (Table 2). The DORs and sensitivities of
akinesia/hypokinesia and LVEF < 55 % as screening tools
for diagnosis of CAD were relatively higher than the other
conditional ratios (Table 2). LVAW akinesia/hypokine-
sia achieved the highest DOR (mean 9.7 %; range, 1.2–
76.2 %), sensitivity (95 %), and NPV (96.4 %) com-
pared with the other locations (Table 3). Specificities
and PPVs were equally poor in all types of akinesia/
hypokinesia (Table 3).
Discussion
Presence of LV akinesia/hypokinesia and/or LVEF < 55 %
significantly increased the odds of having ACA in pa-
tients undergoing DCC. Currently, LVWM and LVEF
are important indicators of LVF, and are commonly used
to assess severity and prognosis of CAD [2]. In one
study, echocardiographic estimates of LVEF were vali-
dated using ventriculography measurements of LVEF for
comparison; LVWM-derived estimates of ejection frac-
tion faithfully reflected LVEF measured by the standard
reference method [16]. Another study by Squeri et al. [3]
Fig. 1 Distribution of akinesia/hypokinesia among the studied groups
Fig. 2 Distribution of left ventricular ejection fraction values (< or ≥ 55 %) among the studied groups
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demonstrated the intimate relationship between LVEF
and severity of CAD. They assessed stress-induced
changes in LVEF (ΔLVEF) in four groups: controls, and
patients with single-, two-, and three-vessel disease. The
results showed that mean ΔLVEF was negative in pa-
tients with three-vessel or left main CAD, indicating that
decreased heart contractility followed stress-induced
myocardial ischemia [3]. In addition, the ΔLVEF was sig-
nificantly lower in all other angiographic groups com-
pared with the controls [3]. These previous findings thus
reflect the efficiency of LVEF in evaluating the severity
of CAD. The present study found that major impairment
of LVWM and LVEF increased the odds of having ACA
by about five to six times, which gives further support to
the findings reported by Squeri et al. [3].
In the present study, the relatively higher sensitivity
compared with specificity of akinesia/hypokinesia and
LVEF < 55 % as screening tools for ACA suggests that
these tests are more efficient in detecting, but not
excluding, patients with ACA [17]. The higher NPV
relative to PPV suggests a higher proportion of NCA
subjects in those with normal LVF compared with the
proportion of ACA patients in those with akinesia/
hypokinesia and LVEF < 55 % [18]. PPV and NPV are
influenced by the disease prevalence [19]; higher preva-
lence tends to result in increased PPV and decreased NPV
[20]. The prevalence of CAD is relatively lower in Sudan
compared with developed countries, and is therefore likely
to have affected the PPV and NPV assessed in the
present study [21]. Hence, LV akinesia/hypokinesia
and LVEF < 55 % were also evaluated by LRP and
LRN, which showed comparable findings to PPV and
NPV [22, 23]. According to the LRP results, akinesia/
hypokinesia and LVEF < 55 % was 1.5 times more
likely in cases with ACA than those with NCA. The
LRN values suggested that normal LVF was 0.3 times
more likely in cases with ACA than those with NCA.
The wide gap between sensitivity and specificity, as
well as between PPV and NPV, indicates poor overall
DA of akinesia/hypokinesia and LVEF < 55 % as screening
tests for ACA. The variations in the conditional ratios
were maintained in different locations of akinesia/
hypokinesia when evaluated as screening tests for
ACA. LVAW akinesia/hypokinesia achieved the high-
est DOR, sensitivity, and NPV, and equally poor spe-
cificity and PPV, compared with the other locations
of akinesia/hypokinesia.
Although it is evident from the current results and
previous reports that abnormal LVWM and LVEF are
common in CAD patients, the presence of such findings
cannot exclude microvascular ischemia. The coexistence
of angina and ischemic ECG changes with uneventful
DCC in patients with NCA in the current study is highly
suggestive of CSX in this group [7, 8]. According to one
study, when CSX patients are subjected to exercise, LV
function is maintained as long as there is no ST segment
shift; worsening of LV function is proportional to the
Table 2 Evaluation of akinesia/hypokinesia and left ventricular
ejection fraction < 55 % as screening tests for coronary artery
disease
Akinesia/Hypokinesia EF < 55 %
Estimate (95 % CI) Estimate (95 % CI)
Sensitivity (%) 87.2 (74.8–94.0) 88.9 (76.5–95.2)
Specificity (%) 41.5 (29.2–54.9) 41.8 (29.7–55.0)
PPV (%) 56.9 (45.4–67.7) 55.6 (44.1–66.5)
NPV (%) 78.6 (60.5–89.8) 82.1 (64.4–92.1)
DA (%) 63.0 (53.2–71.8) 63.6 (53.8–72.4)
LRP 1.5 (1.4–1.6) 1.5 (1.4–1.6)
LRN 0.3 (0.2–0.5) 0.3 (0.2–0.4)
DOR 4.8 (1.8–13.4) 5.8 (2.0–16.8)
EF ejection fraction, CI confidence intervals, PPV positive predictive value, NPV
negative predictive value, DA diagnostic accuracy, LRP likelihood ratio of a
positive test, LRN likelihood ratio of a negative test, DOR diagnostic odds ratio
Table 3 Evaluation of different locations of left ventricular akinesia/hypokinesia in the screening of coronary artery disease
Anterior wall akinesia/Hypokinesia
estimate (95 % CI)
Septal akinesia/Hypokinesia
estimate (95 % CI)
Inferior wall akinesia/Hypokinesia
estimate (95 % CI)
Sensitivity (%) 95.0 (76.4–99.1) 89.3 (72.8–96.3) 87.0 (67.9–95.5)
Specificity (%) 33.8 (24.4–44.6) 34.7 (24.8–46.2) 32.5 (23.1–43.5)
PPV (%) 26.4 (17.6–37.6) 34.7 (24.8–46.2) 27.8 (18.8–39.1)
NPV (%) 96.4 (82.3–99.4) 89.3 (72.8–96.3) 89.3 (72.8–96.3)
DA (%) 46.0 (36.6–55.7) 50.0 (40.4–59.6) 45.0 (35.6–54.8)
LRP 1.4 (1.4–1.5) 1.4 (1.3–1.4) 1.3 (1.2–1.4)
LRN 0.1 (0.01–1.2) 0.3 (0.1–0.7) 0.4 (0.2–0.9)
DOR 9.7 (1.2–76.2) 4.4 (1.2–16.1) 3.2 (0.9–11.8)
CI confidence intervals, PPV positive predictive value, NPV negative predictive value, DA diagnostic accuracy, LRP likelihood ratio of a positive test, LRN likelihood
ratio of a negative test, DOR diagnostic odds ratio
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degree of ST segment depression [5]. These findings are
further supported by another study that showed de-
creased myocardial perfusion in 47 % and abnormal wall
motion in 35 % of CSX patients following stress testing
[4]. The same study concluded that microcirculatory
dysfunction of the myocardium in some patients with
CSX can result in concordant transient segmental
LVWM abnormalities and impaired LVEF [4]. The find-
ings of these previous studies on the pattern of changes
in patients with macro- and micro-vascular ischemia ex-
plain the poor performance of akinesia/hypokinesia and
LVEF < 55 % as screening tools for prediction of ACA.
The current study had some limitations. Although 100
DCC candidates were enrolled, a larger sample size
would have enabled more definitive conclusions to be
made regarding the diagnostic accuracy of resting LV
akinesia/hypokinesia in predicting ACA. In addition, the
lack of stress echocardiography testing in Sudan pre-
cluded evaluation of LV akinesia/hypokinesia in the stud-
ied patients during increased heart activity. Combined
evaluation of DCC patients with resting and stress echo-
cardiography tests in the future could offer scientific evi-
dence as to which test has better DA in predicting ACA.
Conclusion
Evaluation of akinesia/hypokinesia and LVEF < 55 % as
screening tools for CAD suggests that these tests were
more reliable for detection, but not exclusion, of patients
with ACA. Overall DA of these measures to discriminate
ACA from NCA was poor, probably owing to the com-
parable influence of macro- and micro-vascular ischemia
on LVF.
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